- Simtra BioPharma Solutions has opened Building H, a more than $250 million expansion at its Bloomington, Indiana, manufacturing campus. The 153,000-square-foot facility adds prefilled syringe, vial and lyophilization capabilities.
- The expansion forms part of Simtra’s global investment strategy, which includes more than $125 million in additional manufacturing capacity in Halle, Germany. The company plans to increase its global filling lines from 11 to 18 by 2027.
Simtra BioPharma Solutions has opened Building H, a more than $250 million expansion of its manufacturing campus in Bloomington, Indiana. The 153,000-square-foot facility adds prefilled syringe, vial and lyophilization capabilities, expanding the CDMO’s capacity to manufacture sterile injectable products.
The opening was marked by a ribbon-cutting ceremony on November 9, attended by company executives, Indiana Governor Mike Braun, Bloomington Mayor Kerry Thomson, government and economic development officials, and community representatives. The expansion is expected to create hundreds of jobs in Bloomington.
Building H is part of Simtra’s broader global expansion strategy. The company has also invested more than $125 million in manufacturing capacity in Halle, Germany, and committed an initial investment of more than $150 million to its Bloomington Park Campus. Across its US and European network, Simtra plans to increase its number of filling lines from 11 to 18 by 2027.
Simtra CEO Franco Negron said the investments are intended to provide the capacity, technology and infrastructure needed to support increasingly complex sterile injectable medicines. COO Ray Guidotti added that the expanded network would give customers greater flexibility in where and how they manufacture their products.
The company said Building H combines advanced manufacturing technology with infrastructure designed to support the consistent supply of injectable products. The expansion adds capacity to Simtra’s existing operations as it continues to develop its manufacturing network in the United States and Europe.
